Marie-France Jilderda, MD, PhD Candidate Surgical Oncology at Leiden University Medical Center in the Netherlands.
New research presented at the San Antonio Breast Cancer Symposium 2024 between December 10 to December 13 suggests that the Breast Cancer Index (BCI) may help identify a subset of postmenopausal women with HR-positive, node-negative breast cancer at minimal risk of recurrence.
Marie-France Jilderda, MD, PhD Candidate Surgical Oncology at Leiden University Medical Center in the Netherlands explained in an interview with The American Journal of Managed Care® (AJMC®) how this could allow these patients to consider shorter or less intensive endocrine therapy, potentially reducing treatment-related adverse effects.
This transcript was lightly edited for clarity.
Transcript
AJMC: What are the potential benefits…